Skip to content
OpenCapital
Get started

Elanco Animal Health Inc. ELAN Q1 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$1.4BBeat by $93.9MDiluted EPS$0.40Beat by $0.06
Revenue estimate$1.3B
EPS estimate$0.34

Next report

Aug 5, 2026 (In 3 weeks)
Revenue estimate$1.3B
EPS estimate$0.28

Financials

Q1 2026

Income statement

See full
Revenue$1.4B+14.9%
Gross profit$785.0M+14.8%
Net income$57.0M-14.9%
EPS (diluted)$0.11-15.4%

Balance sheet

See full
Cash & equivalents$428.0M-12.1%
Total debt$4.3B-1.7%
Total equity$6.5B+2.3%
Total assets$13.2B+2.2%

Cash flow

See full
Operating cash flow$13.0M+425%
CapEx$51.0M-21.5%
Free cash flow-$38.0M+44.9%

Valuation & ratios

Valuation

as of 07/09/26
See full
Market cap$12.33B+128%
Enterprise value$16.22B+73.1%
P/S2.5×+1.3×

Profitability

See full
Gross margin55.1%+0.2pp
Net margin-4.9%-13.6pp
FCF margin6.4%-1.4pp

Returns & leverage

See full
Return on equity-3.8%-9.9pp
Debt / equity0.7×0.0×
Current ratio2.2×-0.6×

Segments

By product

See full
Pet Health$710.0M+11.8%
Cattle$316.0M+16.2%
Poultry$230.0M+21.7%
Swine$96.0M+12.9%
Contract Manufacturing$19.0M+58.3%

By segment

See full
Reportable Segment$1.4B+14.9%

Versus estimates

Revenue

Q1 2026$1.4BBeat by $93.9M
Q4 2025$1.1BBeat by $51.1MQ3 2025$1.1BBeat by $45.2MQ2 2025$1.2BBeat by $151.5MQ1 2025$1.2BBeat by $15.1MQ4 2024$1.0BMiss by $189.9M

Diluted EPS

Q1 2026$0.40Beat by $0.06
Q4 2025$0.13Beat by $0.02Q3 2025$0.19Beat by $0.06Q2 2025$0.26Beat by $0.06Q1 2025$0.37Beat by $0.06Q4 2024$0.14Miss by $0.02

Ask the moment Elanco Animal Health Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Elanco Animal Health Inc. report Q1 2026 earnings?
Elanco Animal Health Inc. (ELAN) reported Q1 2026 earnings on May 6, 2026 before market open.
What were Elanco Animal Health Inc.'s Q1 2026 revenue and EPS?
Elanco Animal Health Inc. reported revenue of $1.4B and diluted EPS of $0.40 for Q1 2026.
Did Elanco Animal Health Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $1.3B by $93.9M. EPS beat the consensus estimate of $0.34 by $0.06.
How did Elanco Animal Health Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 14.9% from $1.2B a year earlier and diluted EPS grew 8.1% from $0.37.
Where can I find Elanco Animal Health Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001739104-26-000027) and the 10-Q periodic report (0001739104-26-000030) directly on SEC EDGAR. The filing index links above go to sec.gov.